CONTACT: BECKY SOGLIN
2130 Medical Laboratories
Iowa City IA 52242
(319) 335-6660; fax (319) 335-8034
Release: Aug. 18, 2000
People with gambling problems invited to participate
in UI study
IOWA CITY, Iowa -- People who are problem gamblers
-- whose gambling is out of control and leading to personal distress and/or
marital, legal and financial difficulties -- are invited to participate in
a University of Iowa Health Care treatment study. The study will examine the
effectiveness of bupropion in treating pathological gambling. Bupropion, also
known as Wellbutrin or Zyban, already is approved by the Food and Drug Administration
for treating depression and smoking addiction.
Participants must be age 18 or older and cannot be
depressed or abusing alcohol or drugs. In addition, participants cannot have
any eating disorder or a history of seizures. Women must not be pregnant or
planning to get pregnant during the study period. All participants will receive
the study medication. Study participation involves a total of five visits
at the UI over two months. The first visit includes a physical examination.
The four follow-up visits involve assessment of the participant's gambling
and other problems as well as a discussion of the medication and its side
For more information, contact the study's lead investigator,
Donald W. Black, M.D., UI professor of psychiatry at (319) 353-4431.
University of Iowa Health Care describes the partnership
between the UI College of Medicine and the UI Hospitals and Clinics and the
patient care, medical education and research programs and services they provide.